Education
About Us
Working with TipRanks
Follow Us
Clariant AG (CH:CLN)
:CLN
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.37Last Year’s EPS
0.48Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 29, 2025
|% Change Since: 0.76%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted positive aspects such as slight sales growth, EBITDA improvement, and successful cost savings initiatives. However, significant challenges were noted, including declines in the Catalysts segment, restructuring charges, and an uncertain economic environment due to trade tensions. Overall, while there are positive achievements, the negative aspects present significant challenges.Company Guidance
During the Clariant First Quarter Figures 2025 Conference Call, the company provided detailed guidance for the upcoming year. Clariant reported sales of CHF 1.013 billion, marking a 1% increase in local currencies, with EBITDA before exceptional items rising by 3% to CHF 190 million, resulting in a margin of 18.8%. The company completed a CHF 175 million cost savings program and launched a new initiative targeting CHF 80 million in savings by 2027, with CHF 3 million already achieved in Q1. Clariant maintained its guidance for 2025, expecting local currency sales growth at the lower end of the 3% to 5% range and an underlying EBITDA margin of 17% to 18% before exceptional items. The restructuring charges for 2025 are anticipated to be CHF 75 million. The company highlighted strong operational performance in its Lucas Meyer Cosmetics division, achieving sales of CHF 25 million. Despite a challenging environment, Clariant underscored its commitment to improving cash conversion and achieving medium-term targets by 2027.Slight Increase in Sales
Clariant reported sales of CHF 1.013 billion, representing a 1% increase in local currencies with stable performance in Swiss francs.
EBITDA Improvement
The company's EBITDA before exceptional items increased by 3% to CHF 190 million, with a margin improvement of 70 basis points to 18.8%.
Cost Savings Achievement
Completion of CHF 175 million cost savings program, contributing to margin improvements and operational leverage.
Lucas Meyer Cosmetics Performance
Strong operational performance with sales of CHF 25 million and high profitability. Recognized with six innovation awards at the in-cosmetics Global trade show.
Strong Performance in Care Chemicals
Recorded 2% organic growth in local currency with a strong margin of 21.7%.
---
CH:CLN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CH:CLN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 29, 2025 | CHF9.23 | CHF9.54 | +3.41% |
Feb 28, 2025 | CHF10.57 | CHF9.99 | -5.44% |
Oct 29, 2024 | CHF12.76 | CHF12.11 | -5.09% |
Jul 30, 2024 | CHF14.52 | CHF13.36 | -7.99% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Clariant AG (CH:CLN) report earnings?
Clariant AG (CH:CLN) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Clariant AG (CH:CLN) earnings time?
Clariant AG (CH:CLN) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Clariant AG stock?
The P/E ratio of Clariant AG is N/A.
What is CH:CLN EPS forecast?
CH:CLN EPS forecast for the fiscal quarter 2025 (Q2) is 0.37.
---